Fig. 2From: TP53 missense mutation reveals gain-of-function properties in small-sized KRAS transformed pancreatic ductal adenocarcinomaKaplan–Meier curves for patients with TP53 missense or truncating mutation (A, B) in resectable cases, (C, D) in patients with small-sized tumor, (E, F) in patients who failed to receive chemotherapy and (G, H) in patients who received chemotherapy. DFS and OS were displayed as median [95% CI]. NA indicated not availableBack to article page